Introduced
by
To authorize fines of up to $250,000, and up to $1 million on a third or subsequent violation, for a pharmaceutical maker that fails to report information about human clinical trials conducted or sponsored in this state, as House Bill 5389 would mandate.
Referred to the Committee on Health Policy